🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalHas anyone dealt with german private insurance (pkv) vs statutory (gkv)? Page 7

Has anyone dealt with german private insurance (pkv) vs statutory (gkv)?

B12Beth Wed, Apr 16, 2025 at 1:17 AM 36 replies 1,942 viewsPage 7 of 8
ZaraB_AL
Member
456
1,678
Jan 2025
Alabama
Oct 4, 2025 at 11:53 AM#31
B12Beth said:
Update: approved on the third attempt after a peer-to-peer.

This matches mine closely enough to be worth saying so out loud. I had assumed I was the exception until I read this.

12 12JessicaH_TX, KevinCompounds, TirzTom and 9 others
Reply Quote Save Share Report
SallyK_inj
Member
567
2,345
Jul 2024
Iowa
Oct 18, 2025 at 12:27 AM#32
B12Beth said:
Update: approved on the third attempt after a peer-to-peer.

Adding the part of the answer the thread has not reached. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

Ask again with the specifics and you will get a better answer than this one.

11 11bbq_ray_KC, oliver_london, tane_welly and 8 others
Reply Quote Save Share Report
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
Oct 31, 2025 at 12:53 PM#33

The figures, for anyone assembling their own picture. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

10 10jennifer_SEA, tyler_CSCS, VanRx_Mike and 7 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Nov 14, 2025 at 1:11 AM#34

Following on from B12Beth — and this may be the naive question:

Did your prescriber agree with that reading, and if not what was their objection?

9 9andrew_nyc, Dr.EndoEP, GraceAZ_72 and 6 others
Reply Quote Save Share Report
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Nov 27, 2025 at 1:22 PM#35
Dr.GutHealth said:
Say what you would expect to see if you were wrong, before you look.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Filing an objection on the n=1 problem. Personal experience is genuine evidence about one person and very weak evidence about anybody else, and this thread keeps promoting the first into the second.

Correct me if the detail matters more than I have assumed.

8 8emily_PDX, Dr.SleepRoch, laura_annarbor and 5 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register